Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease

NCT07719543 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Immunoglobulin G4-Related Disease

Interventions

DRUG: Lenalidomide
DRUG: Placebo

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]